Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The treatment was ineffective in humans.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Tofacitinib may help treat hair loss in children with alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib might be used to treat hair loss.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Blocking IL-8 can reduce skin rashes from cancer treatment.